The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orodispersible Tablets Market Research Report 2025
Synopsis
An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orodispersible Tablets market was valued at US$ 15320 million in 2023 and is anticipated to reach US$ 33020 million by 2030, witnessing a CAGR of 11.7% during the forecast period 2024-2030.
The orodispersible tablets market is driven by the increasing demand for patient-friendly and convenient drug delivery systems and the growing focus on improving medication adherence. Orodispersible tablets, also known as orally disintegrating tablets or melt-in-mouth tablets, are designed to dissolve rapidly in the mouth without the need for water, making them easier to swallow, especially for patients who have difficulty swallowing conventional tablets or capsules. The rise in the aging population and the prevalence of chronic diseases contribute to market growth, as these patient populations often face challenges in taking oral medications. Moreover, advancements in formulation technology and taste-masking techniques have improved the palatability and acceptance of orodispersible tablets. However, the market also faces challenges, including the cost of development and manufacturing of specialized formulations and addressing stability and shelf-life concerns. Additionally, obtaining regulatory approvals and ensuring consistent quality and performance can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer a diverse range of orodispersible tablet formulations, collaborate with healthcare providers to address specific patient needs, and address the challenges to meet the increasing demand for patient-friendly and effective drug delivery solutions.
This report aims to provide a comprehensive presentation of the global market for Orodispersible Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orodispersible Tablets.
Report Scope
The Orodispersible Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orodispersible Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orodispersible Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orodispersible Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orodispersible Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orodispersible Tablets market was valued at US$ 15320 million in 2023 and is anticipated to reach US$ 33020 million by 2030, witnessing a CAGR of 11.7% during the forecast period 2024-2030.
The orodispersible tablets market is driven by the increasing demand for patient-friendly and convenient drug delivery systems and the growing focus on improving medication adherence. Orodispersible tablets, also known as orally disintegrating tablets or melt-in-mouth tablets, are designed to dissolve rapidly in the mouth without the need for water, making them easier to swallow, especially for patients who have difficulty swallowing conventional tablets or capsules. The rise in the aging population and the prevalence of chronic diseases contribute to market growth, as these patient populations often face challenges in taking oral medications. Moreover, advancements in formulation technology and taste-masking techniques have improved the palatability and acceptance of orodispersible tablets. However, the market also faces challenges, including the cost of development and manufacturing of specialized formulations and addressing stability and shelf-life concerns. Additionally, obtaining regulatory approvals and ensuring consistent quality and performance can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer a diverse range of orodispersible tablet formulations, collaborate with healthcare providers to address specific patient needs, and address the challenges to meet the increasing demand for patient-friendly and effective drug delivery solutions.
This report aims to provide a comprehensive presentation of the global market for Orodispersible Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orodispersible Tablets.
Report Scope
The Orodispersible Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orodispersible Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orodispersible Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orodispersible Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orodispersible Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orodispersible Tablets Market Overview
1.1 Product Overview and Scope of Orodispersible Tablets
1.2 Orodispersible Tablets Segment by Type
1.2.1 Global Orodispersible Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Orodispersible Tablets Segment by Application
1.3.1 Global Orodispersible Tablets Market Value by Application: (2024-2030)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Global Orodispersible Tablets Market Size Estimates and Forecasts
1.4.1 Global Orodispersible Tablets Revenue 2019-2030
1.4.2 Global Orodispersible Tablets Sales 2019-2030
1.4.3 Global Orodispersible Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orodispersible Tablets Market Competition by Manufacturers
2.1 Global Orodispersible Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orodispersible Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orodispersible Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Orodispersible Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orodispersible Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orodispersible Tablets, Product Type & Application
2.7 Orodispersible Tablets Market Competitive Situation and Trends
2.7.1 Orodispersible Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orodispersible Tablets Players Market Share by Revenue
2.7.3 Global Orodispersible Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orodispersible Tablets Retrospective Market Scenario by Region
3.1 Global Orodispersible Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orodispersible Tablets Global Orodispersible Tablets Sales by Region: 2019-2030
3.2.1 Global Orodispersible Tablets Sales by Region: 2019-2024
3.2.2 Global Orodispersible Tablets Sales by Region: 2025-2030
3.3 Global Orodispersible Tablets Global Orodispersible Tablets Revenue by Region: 2019-2030
3.3.1 Global Orodispersible Tablets Revenue by Region: 2019-2024
3.3.2 Global Orodispersible Tablets Revenue by Region: 2025-2030
3.4 North America Orodispersible Tablets Market Facts & Figures by Country
3.4.1 North America Orodispersible Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orodispersible Tablets Sales by Country (2019-2030)
3.4.3 North America Orodispersible Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orodispersible Tablets Market Facts & Figures by Country
3.5.1 Europe Orodispersible Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orodispersible Tablets Sales by Country (2019-2030)
3.5.3 Europe Orodispersible Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orodispersible Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Orodispersible Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orodispersible Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Orodispersible Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orodispersible Tablets Market Facts & Figures by Country
3.7.1 Latin America Orodispersible Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orodispersible Tablets Sales by Country (2019-2030)
3.7.3 Latin America Orodispersible Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orodispersible Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Orodispersible Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orodispersible Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orodispersible Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orodispersible Tablets Sales by Type (2019-2030)
4.1.1 Global Orodispersible Tablets Sales by Type (2019-2024)
4.1.2 Global Orodispersible Tablets Sales by Type (2025-2030)
4.1.3 Global Orodispersible Tablets Sales Market Share by Type (2019-2030)
4.2 Global Orodispersible Tablets Revenue by Type (2019-2030)
4.2.1 Global Orodispersible Tablets Revenue by Type (2019-2024)
4.2.2 Global Orodispersible Tablets Revenue by Type (2025-2030)
4.2.3 Global Orodispersible Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Orodispersible Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orodispersible Tablets Sales by Application (2019-2030)
5.1.1 Global Orodispersible Tablets Sales by Application (2019-2024)
5.1.2 Global Orodispersible Tablets Sales by Application (2025-2030)
5.1.3 Global Orodispersible Tablets Sales Market Share by Application (2019-2030)
5.2 Global Orodispersible Tablets Revenue by Application (2019-2030)
5.2.1 Global Orodispersible Tablets Revenue by Application (2019-2024)
5.2.2 Global Orodispersible Tablets Revenue by Application (2025-2030)
5.2.3 Global Orodispersible Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Orodispersible Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Orodispersible Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Orodispersible Tablets Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Orodispersible Tablets Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Orodispersible Tablets Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson and Johnson Orodispersible Tablets Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Orodispersible Tablets Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Orodispersible Tablets Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly and Company Orodispersible Tablets Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Orodispersible Tablets Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Orodispersible Tablets Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Conquer
6.11.1 Conquer Corporation Information
6.11.2 Conquer Orodispersible Tablets Description and Business Overview
6.11.3 Conquer Orodispersible Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Conquer Orodispersible Tablets Product Portfolio
6.11.5 Conquer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orodispersible Tablets Industry Chain Analysis
7.2 Orodispersible Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orodispersible Tablets Production Mode & Process
7.4 Orodispersible Tablets Sales and Marketing
7.4.1 Orodispersible Tablets Sales Channels
7.4.2 Orodispersible Tablets Distributors
7.5 Orodispersible Tablets Customers
8 Orodispersible Tablets Market Dynamics
8.1 Orodispersible Tablets Industry Trends
8.2 Orodispersible Tablets Market Drivers
8.3 Orodispersible Tablets Market Challenges
8.4 Orodispersible Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
